Skip to Main Content

In a setback for GlaxoSmithKline (GSK), a federal judge upheld a $3 million verdict in a closely watched trial that involved a highly contentious issue — whether consumers can successfully sue a brand-name drug maker if they suffered harm after taking a pill made by a generic rival.

The verdict was issued last spring in a lawsuit that was brought by Wendy Dolin, the widow of an attorney who committed suicide after taking a generic version of Glaxo’s Paxil antidepressant. The federal court jury decided the drug maker failed to properly warn about the risk of its medicine. On Monday, a Glaxo spokeswoman wrote us that the company plans to appeal the decision.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Not all generic Pharma companies are the same. Teva and Mylan are 2 good ones. You have to have a biologic equivalence but that may not be the same level of efficacy as the original drug. I know that from using generic Prozac.

Comments are closed.